After a successful launch of the Valve for Life Initiative in 2015, we would like to welcome the third country on board – Portugal – that started fully participating in the Initiative in the beginning of 2017 along with Poland and France.
Significant underuse of TAVI procedures when compared to other European countries and a very clear and determined cardiology leadership in Portugal that can address the conduct of the Initiative were one of the reasons for Portugal to be selected as a third pilot country to join the Initiative. The perspectives to improve valvular heart disease treatment, to promote the use of the technology in Portugal and to increase the number of TAVI and mitral procedures thanks to the efforts of the Initiative seems promising and the perspectives to duplicate the success of the other participant countries realistic. Before fully immersing into the Valve for Life Initiative, Portugal committed to provide a multi-dimensional GAP analysis outlining the current situation around TAVI procedures in Portugal and the reasons behind the current low use of TAVI.
Some data on the TAVI procedures is already available to help to understand the situation around TAVI in Portugal. In particular, a registry with a completed follow-up on TAVI procedures is already in place to showcase the importance of TAVI. Also, currently there is an annual meeting organized on TAVI procedures in Portugal.
Valve for Life Initiative aims to bring an even better understanding of the importance of aortic and mitral transcatheter interventions in Portugal, engage national and European stakeholders, promote synergies between the participating countries and in long term to increase the number of TAVI in Portugal.
Consult the latest news in the EAPCI News section
Country coordinators: Profs. Rui Campante Teles and Lino Patricio
Last update: May 2017
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved